NA

ID: ALA4848488

PubChem CID: 25058548

Max Phase: Preclinical

Molecular Formula: C33H30N2O10

Molecular Weight: 614.61

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2[nH]cc(C(=O)C(=O)N[C@@H]3c4cc5c(cc4[C@@H](c4cc(OC)c(OC)c(OC)c4)[C@H]4C(=O)OC[C@@H]43)OCO5)c2c1

Standard InChI:  InChI=1S/C33H30N2O10/c1-39-16-5-6-22-17(9-16)20(12-34-22)30(36)32(37)35-29-19-11-24-23(44-14-45-24)10-18(19)27(28-21(29)13-43-33(28)38)15-7-25(40-2)31(42-4)26(8-15)41-3/h5-12,21,27-29,34H,13-14H2,1-4H3,(H,35,37)/t21-,27+,28-,29+/m0/s1

Standard InChI Key:  GCBGCUJJQSFNFM-MHTDFPPDSA-N

Molfile:  

 
     RDKit          2D

 47 53  0  0  0  0  0  0  0  0999 V2000
   15.3583   -8.5942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2214   -9.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3583   -7.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6349  -12.2735    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7331   -7.5217    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9365   -7.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9281  -11.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3541   -9.4090    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.6432   -7.3596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3851   -9.6211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7455   -8.8520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1398   -7.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0526  -11.4461    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5146   -8.5942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2214  -11.4461    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2633   -8.1951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5146   -7.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9365   -8.5942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9281  -10.2280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5105  -11.0387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6432   -9.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3458  -11.0387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6432   -9.8206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3458  -10.2280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3541   -6.9563    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.6349  -11.4545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1398   -8.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2214   -7.3637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6179   -8.1827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7566  -11.0425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9313  -12.6821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6411   -6.5465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9323   -6.1397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9302   -5.3225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2257   -6.5501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6368   -4.9121    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2214   -4.9158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1384   -4.1050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3386   -3.9371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4803   -5.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9341   -4.6446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1372   -4.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8855   -5.5913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4367   -6.1981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2315   -6.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1879   -6.9765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3894   -7.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 29 12  1  0
  1  8  1  1
 22 24  2  0
  7 19  1  0
 21  1  1  0
 18  6  1  0
 16  5  1  0
 24 23  1  0
  4 26  1  0
  2 14  1  0
  5 17  1  0
 21 23  1  6
 27  1  1  0
 13 22  1  0
 11 14  1  0
 11 16  1  0
  1  3  1  0
 12  3  1  0
 20 15  1  0
 10 27  2  0
 19 23  2  0
  2 18  2  0
 29 27  1  0
  9  3  1  0
 26  7  2  0
 21 18  1  0
 14 17  2  0
  6  9  1  0
 26 22  1  0
 17 28  1  0
 15  7  1  0
  3 25  1  6
 28  6  2  0
 13 30  1  0
  4 31  1  0
  9 32  1  1
 32 33  1  0
 33 34  1  0
 33 35  2  0
 34 36  2  0
 34 37  1  0
 37 38  2  0
 38 39  1  0
 39 41  1  0
 40 37  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 40  1  0
 44 46  1  0
 46 47  1  0
M  END

Associated Targets(Human)

K562/A02 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (163371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 614.61Molecular Weight (Monoisotopic): 614.1900AlogP: 3.91#Rotatable Bonds: 8
Polar Surface Area: 143.64Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.43CX Basic pKa: CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.17Np Likeness Score: 0.71

References

1. Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F..  (2020)  Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).,  208  [PMID:32992133] [10.1016/j.ejmech.2020.112830]
2. Jia Y, Wen X, Gong Y, Wang X..  (2020)  Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.,  200  [PMID:32531682] [10.1016/j.ejmech.2020.112359]

Source